Consequently, PFKFB3 activating processes were correlated to exacerbation of glycolytic activity, with PFKFB3 also being up-regulated in multiple tumors including pancreatic [9], breast [10] and gastric cancer [11]. The gene discussed is PFKFB3; the disease is gastric cancer.